In conclusion, SEPT6 inhibited UBC expression, thereby reducing the overall ubiquitination level, affecting the expression level of downstream cell proliferation-related genes, and thus affecting the malignancy of prostate cancer. Here, SEPTIN6 is linked to prostate carcinoma.